Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Corteva (CTVA)

NYSE: CTVA · Fertilizers & Agricultural Chemicals · Indianapolis, IN

Our rating: Neutral

Call changed from Positive to Neutral at $8.12, moderate conviction, November 19, 2026.

Breaks if: The Neutral call turns Cautious if Corteva's next annual net margin falls below 5%, signaling that generic competition is structurally impounding the crop-protection franchise rather than cyclically compressing it. It turns Positive if the next two annual filings both show net margin at or above 9%, confirming the pricing environment has genuinely turned and the 5× multiple understates through-cycle earning power.

Key figures

Market value$5.3B
Revenue, last 12 months$17.7B
Net income, last 12 months$759M
Free cash flow, last 12 months−$149M
Price to earnings6.9×
Free cash flow yield−2.8%
Dividend yield1.4%
Operating marginn/a
Return on equity3.1%
Beta to the S&P 5000.51
Volatility, annualized32.5%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$2.5B−6.1%$-0.85−$742M
June 30, 2026$6.4B−1.2%$1.73−$588M
March 31, 2026$4.9B11.0%$1.07−$3.0B
December 31, 2025$3.9B−1.7%$-0.81$4.2B
September 30, 2025$2.6B12.6%$-0.47$36M
June 30, 2025$6.5B5.6%$1.92$829M
March 31, 2025$4.4B−1.7%$0.95−$2.2B
December 31, 2024$4.0B7.3%$-0.05$4.0B

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

23 ledger entries and 30 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.